MDIHX
Price
$30.11
Change
-$0.05 (-0.17%)
Updated
Jul 31 closing price
Net Assets
43.73B
RLIEX
Price
$20.64
Change
-$0.15 (-0.72%)
Updated
Jul 31 closing price
Net Assets
1.26B
Interact to see
Advertisement

MDIHX vs RLIEX

MDIHX vs RLIEX Comparison Chart in %
View a ticker or compare two or three
VS
MDIHX vs. RLIEX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDIHX is a Hold and RLIEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 43.7B vs. RLIEX (1.26B). RLIEX pays higher dividends than MDIHX: RLIEX (2.15) vs MDIHX (1.83). MDIHX was incepted earlier than RLIEX: MDIHX (21 years) vs RLIEX (11 years). MDIHX (1.10) is less costly to investors than RLIEX (0.83). RLIEX is a more actively managed with annual turnover of: 45.00 vs. MDIHX (2.00). MDIHX has a lower initial minimum investment than RLIEX: MDIHX (0) vs RLIEX (1000000). MDIHX annual gain was more profitable for investors over the last year : 18.20 vs. RLIEX (11.46). MDIHX return over 5 years is better than : 31.41 vs. RLIEX (13.80).
MDIHXRLIEXMDIHX / RLIEX
Total Expense Ratio1.080.80135%
Annual Report Gross Expense Ratio1.100.83133%
Fund Existence21 years11 years-
Gain YTD10.98410.374106%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets43.7B1.26B3,460%
Annual Yield % from dividends1.832.1585%
Returns for 1 year18.2011.46159%
Returns for 3 years44.3236.51121%
Returns for 5 years31.4113.80228%
Returns for 10 years121.9546.75261%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USLYX54.420.70
+1.30%
JHancock U.S. Global Leaders Growth R2
HIACX56.550.47
+0.84%
Hartford Capital Appreciation HLS IA
DFQTX49.480.16
+0.32%
DFA US Core Equity 2 I
TSLCX5.80N/A
N/A
Transamerica Small Cap Value C
HWMAX69.28-0.14
-0.20%
Hotchkis & Wiley Mid-Cap Value A